OTC - ACTIVE INGREDIENT SECTION
Active Ingredients
Camphor 4.7%
Menthol 1.0%
Eucalyptus Oil 1.0%
Active Ingredients
Camphor 4.7%
Menthol 1.0%
Eucalyptus Oil 1.0%
Purpose Cough Suppressant
Do not use on children under 2 years unless directed by doctor
Directions
adults and children 2 years and over;
rub a thick layer on chest and throat or rub on sore aching muscles;
keep clothing loose around chest/throat to help vapors reach the nose/mouth;
repeat up to 3 times per 24 hours or as directed by doctor;
do not use on children under 2 years unless directed by doctor
Inactive ingredients
cedar leaf oil, mineral oil, nutmeg oil, petrolatum, thymol, turpentine oil.
Warnings
For external use only, avoid contact with eyes.
Do not use by mouth, in nostrils, with tight bandages, on wounds or damaged skin
Ask doctor before use if you have,
cough that occurs with too much phlegm (mucus
persistent or chronic cough such as occurs with asthma, emphysema, or smoking
When using this product, do not| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1042786 | camphor 4.7 % / eucalyptus oil 1 % / menthol 1 % Topical Ointment | PSN | 3 |
| 1042786 | camphor 0.047 MG/MG / Eucalyptus oil 0.01 MG/MG / menthol 0.01 MG/MG Topical Ointment | SCD | 3 |
| 1042786 | camphor 4.7 % / eucalyptus oil 1 % / menthol 1 % Topical Ointment | SY | 3 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 29500-9033-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-2e60-f424-e053-dadaa90a57ce | Vaporizing Chest |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 29500-9033-1 | Vaporizing Chest | 113 g in 1 JAR | SALVE | 113 | 3 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 29500-9033 | VAPORIZING CHEST (CAMPHOR, MENTHOL, EUCALYPTUS) SALVE [PERSONAL CARE PRODUCTS] | 3 | Legacy NDC, 1 package rows | 20111122_ce3da72e-5e75-486d-85d3-f7ba5fdca474.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CAMPHOR (SYNTHETIC) | ACTIVE INGREDIENT | 5TJD82A1ET | 3 | |
| EUCALYPTUS OIL | ACTIVE INGREDIENT | 2R04ONI662 | 3 | |
| MENTHOL | ACTIVE INGREDIENT | L7T10EIP3A | 3 | |
| CAMPHOR (SYNTHETIC) | ACTIVE MOIETY | 5TJD82A1ET | 3 | |
| EUCALYPTUS OIL | ACTIVE MOIETY | 2R04ONI662 | 3 | |
| MENTHOL | ACTIVE MOIETY | L7T10EIP3A | 3 | |
| CEDAR LEAF OIL | INACTIVE INGREDIENT | BJ169U4NLG | 3 | |
| MINERAL OIL | INACTIVE INGREDIENT | T5L8T28FGP | 3 | |
| NUTMEG OIL | INACTIVE INGREDIENT | Z1CLM48948 | 3 | |
| PETROLATUM | INACTIVE INGREDIENT | 4T6H12BN9U | 3 | |
| THYMOL | INACTIVE INGREDIENT | 3J50XA376E | 3 | |
| TURPENTINE | INACTIVE INGREDIENT | XJ6RUH0O4G | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 29500-9033 | 29500-9033-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CAMPHOR (SYNTHETIC) | 5TJD82A1ET | ACTIB |
| MENTHOL | L7T10EIP3A | ACTIB |
| EUCALYPTUS OIL | 2R04ONI662 | ACTIB |
| CEDAR LEAF OIL | BJ169U4NLG | IACT |
| MINERAL OIL | T5L8T28FGP | IACT |
| NUTMEG OIL | Z1CLM48948 | IACT |
| PETROLATUM | 4T6H12BN9U | IACT |
| THYMOL | 3J50XA376E | IACT |
| TURPENTINE | XJ6RUH0O4G | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| PETROLATUM | PETROLATUM | 4T6H12BN9U | SOAP / TOPICAL | 0.85 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / OPHTHALMIC | 88.4 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | LOTION / TOPICAL | 25 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUPPOSITORY / RECTAL | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SYSTEM / TOPICAL | 654.36 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | GEL / TOPICAL | 2.5 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUSPENSION / OPHTHALMIC | 0.1 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, COATED / ORAL | 1.5 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | EMULSION / TOPICAL | 7.8 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUSPENSION / TOPICAL | 82 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, DELAYED RELEASE / ORAL | 5.67 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | CREAM / TOPICAL | 2772 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET / ORAL | 113.75 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUSPENSION / AURICULAR (OTIC) | 0.5 %w/v | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT, AUGMENTED / TOPICAL | 81.94 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | TABLET, EXTENDED RELEASE / ORAL | 0.18 mg | ||
| THYMOL | THYMOL | 3J50XA376E | LIQUID / RESPIRATORY (INHALATION) | 0.01 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | CAPSULE / ORAL | 120 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | SUPPOSITORY / VAGINAL | 27 mg | ||
| THYMOL | THYMOL | 3J50XA376E | POWDER, FOR SOLUTION / ORAL | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | PASTE / DENTAL | 95 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | SPONGE / TOPICAL | NA | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CREAM, AUGMENTED / TOPICAL | 26 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | CREAM / VAGINAL | 402 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | OINTMENT / TOPICAL | 9938 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | LIQUID / RESPIRATORY (INHALATION) | NA | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / VAGINAL | 4084 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SOAP / TOPICAL | 0.82 %w/w | ||
| NUTMEG OIL | NUTMEG OIL | Z1CLM48948 | ELIXIR / ORAL | 4.5 mg/5ml | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CAPSULE, EXTENDED RELEASE / ORAL | 0.07 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | CAPSULE, EXTENDED RELEASE / ORAL | 120 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CAPSULE / VAGINAL | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SYSTEM / TRANSDERMAL | 6.09 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | PASTE / TOPICAL | 47.5 %w/w | ||
| NUTMEG OIL | NUTMEG OIL | Z1CLM48948 | LIQUID / RESPIRATORY (INHALATION) | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUPPOSITORY / VAGINAL | 30 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SPRAY / TOPICAL | 1379 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | AEROSOL, FOAM / TOPICAL | 7.9 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / AURICULAR (OTIC) | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | OINTMENT / OPHTHALMIC | 59.5 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / TOPICAL | 7275 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | DROPS / ORAL | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | FILM, EXTENDED RELEASE / TRANSDERMAL | 34 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | FILM / TRANSDERMAL | 11.42 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CREAM / TOPICAL | 4213 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | OIL / TOPICAL | 43.29 %v/v | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | OINTMENT / AURICULAR (OTIC) | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | LOTION / TOPICAL | 1428 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | TABLET / ORAL | 3.5 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, CHEWABLE / ORAL | 6 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, FILM COATED / ORAL | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, EXTENDED RELEASE / ORAL | NA |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 163dd1a2-964c-4184-82e2-7f965d81714b | ce3da72e-5e75-486d-85d3-f7ba5fdca474 | 2011-11-21 | Warnings | 163dd1a2-964c-4184-82e2-7f965d81714b ce3da72e-5e75-486d-85d3-f7ba5fdca474 |
Adverse event summaries are temporarily unavailable. Other product information remains available.